Alligator Bioscience Q1 2025: TO12 Now Crucial - Redeye

Redeye comments on Alligator's first quarter 2025, during which a rights issue of gross SEK150m was conducted and new positive 24-month data presented. The object of the rights issue was to repay loans, so the cash position is still limited, and the company needs proceeds from TO12 in May.

Länk till analysen i sin helhet: https://www.redeye.se/research/1097415/alligator-bioscience-q1-2025-to12-now-crucial?utm_source=finwire&utm_medium=RSS